Statins: Cardiovascular Risk Reduction in Percutaneous Coronary Intervention—Basic and Clinical Evidence of Hyperacute Use of Statins
Reduction of LDL-cholesterol concentration in serum, blocking the isoprenylation of GTPases and the activation of myocyte-protective enzyme systems are three mechanisms that currently explain the lipid and non-lipid effects of statins. However, the decrease of LDL-cholesterol, the reduction of infla...
Saved in:
| Main Authors: | Enrique C. Morales-Villegas, Germano Di Sciascio, Carlo Briguori |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | International Journal of Hypertension |
| Online Access: | http://dx.doi.org/10.4061/2011/904742 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01) -
HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE?
by: I. S. Yavelov, et al.
Published: (2017-09-01) -
Reduction of cardiovascular risk in rheumatoid arthritis: double benefit of statins
by: Diana Sergeevna Novikova, et al.
Published: (2010-12-01) -
STATINS IN ACUTE CORONARY SYNDROMES
by: A. L. Alyavi, et al.
Published: (2019-03-01) -
Statins in acute coronary syndrome
by: O. M. Drapkina
Published: (2009-10-01)